Europe reviews Valneva's chikungunya vaccine after reports of serious side-effects in older people
Companies
Valneva SE
Follow
May 7 (Reuters) - The European Union's health regulator said on Wednesday it has begun a review of Valneva's (VLS.PA)
, opens new tab chikungunya vaccine after reports of serious adverse events in older adults, including two deaths globally.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Reporting by Mariam Sunny in Bengaluru; Editing by Tasim Zahid
Our Standards: The Thomson Reuters Trust Principles. , opens new tab
Share X
Link
Purchase Licensing Rights
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
AI chatbots ‘highly vulnerable' to repeating false medical information, experts warn
AI chatbots are frequently prone to repeating false and misleading medical information, according to new research. Experts have warned of a 'critical need' for stronger safeguards before the bots can be used in healthcare, adding models not only repeated untrue claims but also 'confidently' expanded on them to create explanations for non-existent medical conditions. The team from the Mount Sinai School of Medicine created fictional patient scenarios, each containing one fabricated medical terms such as a made-up disease, symptom, or test, and submitted them to leading large language models. In a study published in journal Communications Medicine, they said that the chatbots 'routinely' expanded on the fake medical detail, giving a 'detailed, decisive response based entirely on fiction'. But their research also found that by adding one small prompt reminding the model the information provided might be inaccurate, errors could be reduced 'significantly'. 'Our goal was to see whether a chatbot would run with false information if it was slipped into a medical question, and the answer is yes,' said co-corresponding senior author Eyal Klang, MD, from the Icahn School of Medicine at Mount Sinai. 'Even a single made-up term could trigger a detailed, decisive response based entirely on fiction. 'But we also found that the simple, well-timed safety reminder built into the prompt made an important difference, cutting those errors nearly in half. That tells us these tools can be made safer, but only if we take prompt design and built-in safeguards seriously.' Co-author Dr Girish Nadkarni said the solution wasn't to 'abandon AI in medicine' but to 'ensure human oversight remains central'. The team hope their work can help introduce a simple 'fake-term' method for tech developers to use in testing medical AI systems. 'Our study shines a light on a blind spot in how current AI tools handle misinformation, especially in health care,' he said. 'It underscores a critical vulnerability in how today's AI systems deal with misinformation in health settings. 'A single misleading phrase can prompt a confident yet entirely wrong answer. The solution isn't to abandon AI in medicine, but to engineer tools that can spot dubious input, respond with caution, and ensure human oversight remains central. We're not there yet, but with deliberate safety measures, it's an achievable goal.' It comes after research last year showed many popular AI chatbots, including ChatGPT and Google's Gemini, lack adequate safeguards to prevent the creation of health disinformation when prompted. They found several large language models consistently created blog posts on false information, including the claim suncream causes skin cancer, when asked.
Daily Mail
2 hours ago
- Daily Mail
Experts say no more covid jabs in the UK
Health chiefs were today begged to re-examine the UK's Covid jab policy after ditching plans to offer the jabs to under 75s this winter. Invites won't be dished out to up to six million pensioners aged 65-74, who were eligible during the pandemic. Scientists were alarmed last month after a new Covid variant dubbed 'Stratus' and believed to to be more infectious than previous Covid strains, soared to dominance in the UK. But the Joint Committee on Vaccination and Immunization (JCVI), which guides ministers on jab rollouts, argued that additional Covid doses provide 'very limited, if any, protection against infection' given the 'high population immunity' to the virus. Dr Leyla Hannbeck, chief executive of the Independent Pharmacies Association, said the JCVI's decision was a 'hugely concerning, a reckless decision'. She added: 'By restricting access to jabs this autumn ahead of peak Covid season, there is a serious risk that Covid cases in this age group increase compared to previous years putting even greater pressure on the NHS. She also said it was 'madness' for the UK to restrict jabs, when other nations including Germany and the United States were still recommending the vaccines for all pensioners. 'To deny millions of seniors their COVID jab this year is to take an unacceptable risk with patient health and risks producing a winter crisis the NHS simply won't be able to cope with,' Dr Hannbeck added. A Department of Health and Social Care (DHSC) spokesperson said: 'This decision is based on expert advice from the JCVI, which continuously monitor and evaluate emerging scientific evidence on Covid vaccines. 'The autumn 2025 vaccination program will target people who are at the highest risk of serious illness to protect the most vulnerable. We encourage anyone who is eligible for Covid vaccination to come forward for vaccination this autumn.' In the UK, ministers have repeatedly said they won't resort to imposing lockdowns unless a doomsday Covid variant appears. A wall of immunity among the population—built up by repeated waves of infection and vaccine rollouts—has given officials confidence to consign pandemic-era measures to history.
Reuters
2 hours ago
- Reuters
US Senators Wyden, Warren launch probe into UnitedHealth's nursing home practices
Aug 7 (Reuters) - U.S. Senators Ron Wyden and Elizabeth Warren are launching an investigation into UnitedHealth Group (UNH.N), opens new tab related to allegations that the company secretly paid nursing homes thousands in bonuses to cut hospital transfers of sick residents. In a letter dated August 6 to UnitedHealth CEO Stephen Hemsley, the senators called on the healthcare conglomerate to provide detailed information about its reported incentive programming and its impact on the nursing home residents. This follows a May report from the UK's Guardian that the company made secret payments to nursing homes, as part of a series of cost-cutting tactics that helped the company save millions but risked residents' health, according to an investigation carried out by the newspaper. "Nursing home residents and their families should not live in fear of a for-profit health care company withholding care when it is most critical," the senators said in the letter. They have sought a response from the company by September 8 about its hospitalization policies, directives related to care planning for nursing home residents enrolled in its institutional special needs plans (I-SNPs), marketing practices related to those plans and federal oversight related to them. The company said it has received the Senators' letter and will continue to educate its staff and share information on the I-SNP model and its proven benefit for seniors. The allegations stem from an article that misrepresents a program and the U.S. Department of Justice extensively reviewed these allegations and found no evidence of wrongdoing, UnitedHealth said on Thursday. UnitedHealth is also under investigation by the U.S. DoJ over its Medicare business, a U.S. government program that covers medical costs for individuals aged 65 and older and those with disabilities. The company said in July it is complying with both criminal and civil requests from the federal agency.
